Market Cap 212 Billion
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the company's sales are generated in the United States.
EPS 1.04 P/E Ratio 33.85
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (In 10 days)
Yield 2.60% / $2.20
Ex-Date Fri, Sep 13, 2019 (36 days ago)
Pay Date Mon, Oct 7, 2019
Oct 25, 2018
Aug 29, 2019
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.